Allogene Therapeutics Inc(ALLO-Q)NASDAQ
Today's Change
Real-Time Last Update
After Hours Change
After Hours Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr12/2024 | Next Qtr03/2025 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | -0.36 | -0.37 | -1.38 | -1.45 |
| Number of Estimates | 11 | 6 | 12 | 12 |
| High Estimate | -0.32 | -0.33 | -1.30 | -1.29 |
| Low Estimate | -0.42 | -0.38 | -1.44 | -1.66 |
| Prior Year | -0.43 | -0.38 | -2.01 | -1.38 |
| Growth Rate Est. (year over year) | +16.28% | +2.63% | +31.34% | -5.07% |
Earnings History - Surprises*
| Qtr Ending09/2024 | Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | |
|---|---|---|---|---|
| Reported | $-0.27 | $-0.32 | $-0.38 | $-0.43 |
| Estimate | $-0.34 | $-0.35 | $-0.38 | $-0.47 |
| Difference | +0.07 | +0.03 | unch | +0.04 |
| Surprise | +20.59% | +8.57% | unch | +8.51% |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.39
3 Mths Ago18
4.39
2 Mths Ago18
4.39
1 Mth Ago18
4.39
Current18
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 18 | 18 | 18 | 18 |
12 1 | 12 1 | 12 1 | 12 1 | |
| Holds | 5 | 5 | 5 | 5 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell